Exhibit 99.1 BriaCell Therapeutics Corp. Condensed Interim Consolidated Financial Statements For the Three and Nine Months Ended April 30, 2022 Expressed in United States Dollars (Unaudited) | --- | --- | |-------------------------------------|-------------------------------------| | | | | Corporate Office- Canada | | | Suite 300 - Bellevue Centre | Corporate Office- US | | 235 -15th Street | 2929 Arch Street, 3rd Floor | | West Vancouver, BC V7T 2X1 | Philadelphia, PA 19104 | | Tel : 604-921-1810 | Tel : 1 ...

Exhibit 99.3 BRIACELL THERAPEUTICS CORP. Annual Information Form FOR THE YEAR ENDED JULY 31, 2021 DATED AS OF OCTOBER 28, 2021 TABLE OF CONTENTS | --- | --- | |--------------------------------------------------------------------------|-------| | | | | ANNUAL INFORMATION FORM | 1 | | FORWARD-LOOKING STATEMENTS | 1 | | GLOSSARY OF TERMS | 3 | | CORPORATE STRUCTURE | 6 | | GENERAL DEVELOPMENT OF THE BUSINESS | 7 | | DESCRIPTION OF THE BUSINESS | 11 | | RISK FACTORS | 36 | | DESCRIPTION OF SECURITIES | 55 | | D ...